Attempts by plaintiffs in product liability actions to bootstrap consumer fraud claims to obvious claims of product defect must be rejected wholesale by the American judicial system. The author discusses why.

The key factor in succeeding with either the government contractor defense or the combatant activities exception is the ability to establish that the government exercised its discretion over the manner in which the contract was performed. A look at recent cases demonstrating that these defenses are invaluable tools in defending a broad range of claims against government contractors.

Features

There are several often-overlooked strategies for defending against trade-misappropriation claims. The first I call the Trade Secret Per Se Doctrine. The second pertains to open-source software. Both of these strategies need to be fully considered in appropriate trade-secret misappropriation cases, to which e-commerce counsel are no strangers.

The authors claim that <i>Wyeth v. Levine</i> is a major victory for consumer advocates and champions of the civil justice system. Here's why.

Features

Blogs simultaneously provide Internet users with social-network prospects and employers with a previously unavailable source of information suitable for employment-assessment decisions. And it's in this intersection on the Information Superhighway where often occurs a collision of worlds, perspectives and direction that frequently cripples or kills prospects, and individuals' aspirations. Employees of e-commerce companies aren't immune to such collisions, nor are agents of the companies who gather data on prospective or current employees, if they go about their work unlawfully, or in other improper ways that could lead to legal or other types of regulatory action.

Features

This article explores some of the legal and practical considerations that go into lifting a litigation hold and minimizing the risk of the activity.

Features

The Supreme Court handed down its decision last month in the case of <i>Wyeth v. Levine</i>, ruling that federal law did not bar plaintiff Diana Levine from suing pharmaceutical maker Wyeth over allegedly insufficient drug safety warnings, even though the warnings had been approved by the Food and Drug Administration (FDA). This decision establishes the troubling precedent that a sympathetic jury can now supersede the expert opinions of the FDA on what qualifies as adequate safety labeling.

Features

Recent cases of interest to you and your practice.